(lp0
S"Enanta: Half Cash, All Upside Seeking Alpha - Feb 28, 2017 Investors have likely been disappointed in the past year and three years, but the company's early stage pipeline could breathe new life into shares.Enanta Pharmaceuticals Inc.  Moves Lower on Volume Spike for February 28 - Equities.com"
p1
aS"Enanta Pharmaceuticals Inc. ENTA  Wall Street Journal - Mar 22, 2013 News Enanta Pharmaceuticals Inc.ENTA. Significant News Only. 02/27/17; Press Release. Enanta Announces CHMP Grants Positive Opinion for an Eight-Week Treatment Option with AbbVie's VIEKIRAX  +&nbsp;..."
p2
aS'Enanta Pharmaceuticals, Inc. Common Stock Quote &amp; Summary Data Nasdaq - Nov 8, 2012 We are a research and development-focused biotechnology company that uses our robust, chemistry-driven approach and drug discovery capabilities to create small molecule drugs primarily for the treatment of viral infections and liver diseases.'
p3
aS'Why Enanta Pharmaceuticals Inc. Shares Shot Higher Motley Fool - Dec 10, 2013 What: Shares of Enanta Pharmaceuticals , a small-molecule drug developer targeted at infectious disease, soared as much as 20% after clinical partner AbbVie  reported positive results from its second phase 3 trial of six&nbsp;...AbbVie oral hep C drugs cure 96 percent in late stage trial - Reuters'
p4
aS'Stock Returns: Agios Pharmaceuticals Inc  is Beating Enanta ... CML News - Mar 20, 2017 This is a snapshot to compare the stock returns for Agios Pharmaceuticals Inc  versus Enanta Pharmaceuticals Inc  . The stock return points we compare look at the last three-months, six-months and twelve-months. At the end&nbsp;...Consensus Watch on Enanta Pharmaceuticals, Inc.  - Rockville Register'
p5
aS'Enanta Pharmaceuticals, Inc.  Projected EPS At $-0.38 Stock Observer - 14 hours ago In weighing to preceding quarter, Enanta Pharmaceuticals, Inc. posted EPS of $-0.26 for the period ended on 2016-12-31.Enanta Pharmaceuticals, Inc.  Target Price At $32 - Markets Daily'
p6
aS'A Fundamental Perspective On Enanta Pharmaceuticals Seeking Alpha - Nov 20, 2015 The FDA warning is related to the only approved drugs related to Enanta, thus makes this a very risky investment. Competition from GILD, JNJ and MRK is ... From my continuous market screening, one of the stocks that ticked the right boxes was Enanta ...'
p7
aS"Enanta Pharmaceuticals'  CEO Jay Luly on Q2 2016 Results - Earnings Call ... Seeking Alpha - May 9, 2016 Good afternoon, ladies and gentlemen. Welcome to the Enanta Pharmaceuticals Second Quarter Financial Results Conference Call."
p8
aS'Stock Returns: FibroGen Inc  is Beating Enanta Pharmaceuticals ... CML News - Mar 14, 2017 This is a snapshot to compare the stock returns for Enanta Pharmaceuticals Inc  versus FibroGen Inc  .'
p9
aS"Enanta Pharmaceuticals'  CEO Jay Luly on Q4 2016 Results - Earnings Call ... Seeking Alpha - Nov 22, 2016 I am pleased to report on Enanta's financial results and to update you on the company's progress and outlook for the upcoming year."
p10
a.